Esta guía es una herramienta que ha permitido desde su
primera edición, estandarizar los abordajes clínicos de las enfermedades más frecuentes atendidas a nivel de los hospitales del país. [Nicaragua] En el 2008 el Ministerio de Salud ...ass="attribute-to-highlight medbox">con la participación de otros colaboradores realizó la revisión de la guía
publicada hace 4 años y le incorporó los cambios y adaptaciones necesarios a cada uno de los capítulos tomando como referencia las mejores evidencias científicas actuales. Esto facilitará el abordaje clínico estandarizado de los principales problemas de salud de la niñez usuaria de nuestros servicios.
more
Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained set...tings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.
more
Supplement
HIV testing services
December 2016
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be delivered during pregnancy, childbirth and the postnatal period?
■ What health behaviours should the women practise ...(or not practise) during these periods to care for herself and her baby?
more
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
Journal of Virus Eradication 2016; 2 (Supplement 4): 1–6
Review
first issued 18 August 2022
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...G ne soit pas apparue dans les populations naïves aux TAR incapables
de supprimer la charge virale dans les essais cliniques, certains éléments portent à croire que la résistance au
DTG peut émerger chez les personnes suivant des schémas thérapeutiques incluant le DTG. L’OMS recommande aux
pays qui étendent les TAR incluant le DTG d’accompagner ce déploiement d’une surveillance en routine de la pharmacorésistance
more
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and ...ght medbox">control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that expertise, FIP joined efforts with the PFA and is now publishing its first-ever handbook to support pharmacists in the
area of vector-borne diseases. As the integration of the regional forums in FIP advances, such collaborative projects are tangible results of an increasingly regionally informed and regionally targeted work by FIP.
more
The new five-year agenda of WHO in Africa, The Africa Health Transformation Programme, 2015–2020: a vision for universal health coverage, is the strategic framework that will guide WHO’s contrib...ution to the emerging sustainable development platform in Africa. It articulates a vision for health and development that aims to address the unacceptable inequalities and inequities that have kept our region lagging far behind others in terms of health indices and enjoyment of the highest attainable standard of life.
more
This report brings attention to achieving gender equality in the context of women, girls, and the HIV response. This six-month consultation in 2016 with adolescent women and young girls found that #...WhatWomenWant is: collaboration and joint action by all to invest in women's HIV and Sexual and Reproductive Health and Rights (SRHR), to be leaders and articulate the priorities of women and girls in all their diversity, and to speak to the new Political Declaration on AIDS and the SDG framework as a tool for civil society to meet their agenda to achieve gender equality in the HIV and SRHR response.
more